Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Pain Management for Medical and Surgical Abortion Between 13 and 24 Weeks Gestation: A Systematic Review.

Jackson E, Kapp N.

BJOG. 2020 Mar 11. doi: 10.1111/1471-0528.16212. [Epub ahead of print] Review.

PMID:
32162427
2.

Modern methods to induce abortion: Safety, efficacy and choice.

Kapp N, Lohr PA.

Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:37-44. doi: 10.1016/j.bpobgyn.2019.11.008. Epub 2020 Jan 9. Review.

PMID:
32029379
3.

Label comprehension of a combined mifepristone and misoprostol product for medical abortion: A pilot study in South Africa.

Kapp N, Methazia J, Eckersberger E, Griffin R, Bessenaar T.

Contraception. 2020 Jan;101(1):46-52. doi: 10.1016/j.contraception.2019.09.009. Epub 2019 Oct 23.

PMID:
31655069
4.

Definitions, measurement and indicator selection for quality of care in abortion.

Darney BG, Kapp N, Andersen K, Baum SE, Blanchard K, Gerdts C, Montagu D, Chakraborty NM, Powell B.

Contraception. 2019 Nov;100(5):354-359. doi: 10.1016/j.contraception.2019.07.006. Epub 2019 Jul 26.

PMID:
31356772
5.

Validation of instrument reprocessing methods for the Ipas manual vacuum aspiration devices.

Powell B, Kapp N.

Int J Gynaecol Obstet. 2019 Oct;147(1):89-95. doi: 10.1002/ijgo.12908. Epub 2019 Jul 31.

PMID:
31294825
6.

Medical abortion in the late first trimester: a systematic review.

Kapp N, Eckersberger E, Lavelanet A, Rodriguez MI.

Contraception. 2019 Feb;99(2):77-86. doi: 10.1016/j.contraception.2018.11.002. Epub 2018 Nov 13. Review.

7.

Quality of care and abortion: beyond safety.

Darney BG, Powell B, Andersen K, Baum SE, Blanchard K, Gerdts C, Montagu D, Chakraborty NM, Kapp N.

BMJ Sex Reprod Health. 2018 May 7. pii: bmjsrh-2018-200060. doi: 10.1136/bmjsrh-2018-200060. [Epub ahead of print] No abstract available.

8.

Synergistic in-vitro effects of combining an antiglycolytic, 3-bromopyruvate, and a bromodomain-4 inhibitor on U937 myeloid leukemia cells.

Kapp N, Stander XX, Stander BA.

Anticancer Drugs. 2018 Jun;29(5):429-439. doi: 10.1097/CAD.0000000000000613.

PMID:
29561307
9.

Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.

Kapp N, Baldwin MK, Rodriguez MI.

Contraception. 2018 Feb;97(2):90-99. doi: 10.1016/j.contraception.2017.09.006. Epub 2017 Sep 18.

10.

Developing a forward-looking agenda and methodologies for research of self-use of medical abortion.

Kapp N, Blanchard K, Coast E, Ganatra B, Harries J, Footman K, Moore A, Owolabi O, Rossier C, Shellenberg K, Wahlin B, Woodsong C.

Contraception. 2018 Feb;97(2):184-188. doi: 10.1016/j.contraception.2017.09.007. Epub 2017 Sep 18. No abstract available.

11.

FIGO's updated recommendations for misoprostol used alone in gynecology and obstetrics.

Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, Kapp N, Castleman L, Kim C, Ho PC, Visser GHA.

Int J Gynaecol Obstet. 2017 Sep;138(3):363-366. doi: 10.1002/ijgo.12181. Epub 2017 Jun 23. No abstract available.

12.

A research agenda for moving early medical pregnancy termination over the counter.

Kapp N, Grossman D, Jackson E, Castleman L, Brahmi D.

BJOG. 2017 Oct;124(11):1646-1652. doi: 10.1111/1471-0528.14646. Epub 2017 Apr 27. Review.

14.

A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.

Festin MP, Bahamondes L, Nguyen TM, Habib N, Thamkhantho M, Singh K, Gosavi A, Bartfai G, Bito T, Bahamondes MV, Kapp N.

Hum Reprod. 2016 Mar;31(3):530-40. doi: 10.1093/humrep/dev341. Epub 2016 Jan 31.

15.

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate.

Jesam C, Cochon L, Salvatierra AM, Williams A, Kapp N, Levy-Gompel D, Brache V.

Contraception. 2016 Apr;93(4):310-316. doi: 10.1016/j.contraception.2015.12.015. Epub 2016 Jan 4.

PMID:
26764121
16.

Progestogen-only contraceptive use among breastfeeding women: a systematic review.

Phillips SJ, Tepper NK, Kapp N, Nanda K, Temmerman M, Curtis KM.

Contraception. 2016 Sep;94(3):226-52. doi: 10.1016/j.contraception.2015.09.010. Epub 2015 Sep 26. Review.

17.

A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.

Brache V, Cochon L, Duijkers IJ, Levy DP, Kapp N, Monteil C, Abitbol JL, Klipping C.

Hum Reprod. 2015 Dec;30(12):2785-93. doi: 10.1093/humrep/dev241. Epub 2015 Sep 23.

PMID:
26405263
18.

Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.

Tepper NK, Phillips SJ, Kapp N, Gaffield ME, Curtis KM.

Contraception. 2016 Sep;94(3):262-74. doi: 10.1016/j.contraception.2015.05.006. Epub 2015 May 19. Review.

19.

Imaging with the fluorogenic dye Basic Fuchsin reveals subcellular patterning and ecotype variation of lignification in Brachypodium distachyon.

Kapp N, Barnes WJ, Richard TL, Anderson CT.

J Exp Bot. 2015 Jul;66(14):4295-304. doi: 10.1093/jxb/erv158. Epub 2015 Apr 28.

20.

Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception.

Kapp N, Abitbol JL, Mathé H, Scherrer B, Guillard H, Gainer E, Ulmann A.

Contraception. 2015 Feb;91(2):97-104. doi: 10.1016/j.contraception.2014.11.001. Epub 2014 Nov 8.

PMID:
25528415
21.

Intrauterine device insertion in the postpartum period: a systematic review.

Sonalkar S, Kapp N.

Eur J Contracept Reprod Health Care. 2015 Feb;20(1):4-18. doi: 10.3109/13625187.2014.971454. Epub 2014 Nov 14. Review.

PMID:
25397890
22.

Ulipristal acetate for emergency contraception: postmarketing experience after use by more than 1 million women.

Levy DP, Jager M, Kapp N, Abitbol JL.

Contraception. 2014 May;89(5):431-3. doi: 10.1016/j.contraception.2014.01.003. Epub 2014 Jan 13.

PMID:
24508124
23.

A review of global access to emergency contraception.

Westley E, Kapp N, Palermo T, Bleck J.

Int J Gynaecol Obstet. 2013 Oct;123(1):4-6. doi: 10.1016/j.ijgo.2013.04.019. Epub 2013 Jul 13. Review.

PMID:
23856676
24.

WHO technical and policy guidance emphasizes the health systems' responsibility to provide safe abortion services.

Kapp N, Glasier A.

Contraception. 2013 May;87(5):511-2. doi: 10.1016/j.contraception.2013.02.002. Epub 2013 Feb 13. No abstract available.

PMID:
23489719
25.

WHO recommendations for misoprostol use for obstetric and gynecologic indications.

Tang J, Kapp N, Dragoman M, de Souza JP.

Int J Gynaecol Obstet. 2013 May;121(2):186-9. doi: 10.1016/j.ijgo.2012.12.009. Epub 2013 Feb 19.

PMID:
23433680
26.

A review of evidence for safe abortion care.

Kapp N, Whyte P, Tang J, Jackson E, Brahmi D.

Contraception. 2013 Sep;88(3):350-63. doi: 10.1016/j.contraception.2012.10.027. Epub 2012 Dec 20. Review.

PMID:
23261233
27.

Advance supply of emergency contraception: a systematic review.

Rodriguez MI, Curtis KM, Gaffield ML, Jackson E, Kapp N.

Contraception. 2013 May;87(5):590-601. doi: 10.1016/j.contraception.2012.09.011. Epub 2012 Oct 4. Review.

PMID:
23040139
28.

Initiation of progestogen-only injectables on different days of the menstrual cycle and its effect on contraceptive effectiveness and compliance: a systematic review.

Kapp N, Gaffield ME.

Contraception. 2013 May;87(5):576-82. doi: 10.1016/j.contraception.2012.08.017. Epub 2012 Sep 17. Review.

PMID:
22995541
29.

When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review.

Salcedo J, Rodriguez MI, Curtis KM, Kapp N.

Contraception. 2013 May;87(5):602-4. doi: 10.1016/j.contraception.2012.08.013. Epub 2012 Sep 17. Review.

PMID:
22995538
30.

Who can provide effective and safe termination of pregnancy care? A systematic review*.

Renner RM, Brahmi D, Kapp N.

BJOG. 2013 Jan;120(1):23-31. doi: 10.1111/j.1471-0528.2012.03464.x. Epub 2012 Aug 20. Review.

31.

Acceptability of misoprostol-only medical termination of pregnancy compared with vacuum aspiration: an international, multicentre trial.

Rodriguez MI, Seuc A, Kapp N, von Hertzen H, Huong NT, Wojdyla D, Mittal S, Arustamyan K, Shah R; World Health Organization Research Group on Post-Ovulatory Methods of Fertility Regulation.

BJOG. 2012 Jun;119(7):817-23. doi: 10.1111/j.1471-0528.2012.03310.x. Epub 2012 Mar 20.

32.

Perioperative antibiotics to prevent infection after first-trimester abortion.

Low N, Mueller M, Van Vliet HA, Kapp N.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD005217. doi: 10.1002/14651858.CD005217.pub2. Review.

33.

Medical methods for first trimester abortion.

Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD002855. doi: 10.1002/14651858.CD002855.pub4. Review.

PMID:
22071804
34.

Intrauterine contraceptive insertion postabortion: a systematic review.

Steenland MW, Tepper NK, Curtis KM, Kapp N.

Contraception. 2011 Nov;84(5):447-64. doi: 10.1016/j.contraception.2011.03.007. Epub 2011 May 4. Review.

PMID:
22018119
35.

Postpartum sterilization with the titanium clip: a systematic review.

Rodriguez MI, Edelman AB, Kapp N.

Obstet Gynecol. 2011 Jul;118(1):143-7. doi: 10.1097/AOG.0b013e318220be49. Review. Erratum in: Obstet Gynecol. 2011 Oct;118(4):961.

PMID:
21691172
36.

Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials.

Piaggio G, Kapp N, von Hertzen H.

Contraception. 2011 Jul;84(1):35-9. doi: 10.1016/j.contraception.2010.11.010. Epub 2011 Jan 7.

PMID:
21664508
37.

Clinical guidelines. Labor induction abortion in the second trimester.

Borgatta L, Kapp N; Society of Family Planning.

Contraception. 2011 Jul;84(1):4-18. doi: 10.1016/j.contraception.2011.02.005. Epub 2011 Mar 30.

PMID:
21664506
38.

Intrauterine device insertion after medical abortion.

Betstadt SJ, Turok DK, Kapp N, Feng KT, Borgatta L.

Contraception. 2011 Jun;83(6):517-21. doi: 10.1016/j.contraception.2010.10.006. Epub 2010 Dec 3.

PMID:
21570548
39.

Medical methods for mid-trimester termination of pregnancy.

Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005216. doi: 10.1002/14651858.CD005216.pub2. Review.

PMID:
21249669
40.

Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review.

Jackson E, Kapp N.

Contraception. 2011 Feb;83(2):116-26. doi: 10.1016/j.contraception.2010.07.014. Epub 2010 Aug 30. Review.

PMID:
21237336
41.

Comprehensive analysis of the use of pre-procedure ultrasound for first- and second-trimester abortion.

Kulier R, Kapp N.

Contraception. 2011 Jan;83(1):30-3. doi: 10.1016/j.contraception.2010.06.014. Epub 2010 Aug 5. Review.

PMID:
21134500
42.

Progestogen-only contraceptive use among breastfeeding women: a systematic review.

Kapp N, Curtis K, Nanda K.

Contraception. 2010 Jul;82(1):17-37. doi: 10.1016/j.contraception.2010.02.002. Epub 2010 Mar 29. Review.

PMID:
20682140
43.

Combined oral contraceptive use among breastfeeding women: a systematic review.

Kapp N, Curtis KM.

Contraception. 2010 Jul;82(1):10-6. doi: 10.1016/j.contraception.2010.02.001. Epub 2010 Mar 9. Review.

PMID:
20682139
44.

Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.

Ellis SC, Kapp N, Vragpvoc O, Borgata L.

Contraception. 2010 May;81(5):441-5. doi: 10.1016/j.contraception.2009.12.018. Epub 2010 Feb 1.

PMID:
20399952
45.

Cervical preparation for first trimester surgical abortion.

Kapp N, Lohr PA, Ngo TD, Hayes JL.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD007207. doi: 10.1002/14651858.CD007207.pub2. Review.

46.

Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review.

Curtis KM, Nanda K, Kapp N.

AIDS. 2009 Nov;23 Suppl 1:S55-67. doi: 10.1097/01.aids.0000363778.58203.b6. Review.

PMID:
20081389
47.

Rates of serious infection after medical abortion.

Kapp N, Winikoff B, Blumenthal PD.

N Engl J Med. 2009 Oct 8;361(15):1511-2; author reply 1512. doi: 10.1056/NEJMc091589. No abstract available.

PMID:
19812412
48.

Hormonal contraceptive use among women with liver tumors: a systematic review.

Kapp N, Curtis KM.

Contraception. 2009 Oct;80(4):387-90. doi: 10.1016/j.contraception.2009.01.021. Epub 2009 Jun 10. Review.

PMID:
19751862
49.

The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review.

Kapp N, Tilley IB, Curtis KM.

Contraception. 2009 Oct;80(4):381-6. doi: 10.1016/j.contraception.2009.04.007. Epub 2009 Aug 28. Review.

PMID:
19751861
50.

Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease.

Gaffield ME, Kapp N, Curtis KM.

Contraception. 2009 Oct;80(4):363-71. doi: 10.1016/j.contraception.2009.03.022. Epub 2009 Jun 4. Review.

PMID:
19751859

Supplemental Content

Support Center